HIV T-Cell Vaccines

Advances in Experimental Medicine and Biology
Beatriz Mothe, C Brander

Abstract

Some of the strongest immune correlates of controlled HIV infection include markers related to antiviral T-cell responses, especially responses mediated by CD8+ cytotoxic T lymphocytes (CTL). These observations and lessons learned from other viral infections have motivated the development of T-cell vaccine candidates to HIV in the preventive and especially in the therapeutic setting. While none of the T-cell vaccine concepts tested to date have shown sufficient efficacy, the last few years have seen some advances indicating that strategies activating the cellular adaptive immune response to HIV may present a critical component of an effective therapeutic and possibly preventive HIV vaccine. Some of the important components that a successful T-cell vaccine may need to contain and additional considerations for the design and delivery of such vaccines are discussed in this chapter.

Citations

Oct 5, 2019·Human Vaccines & Immunotherapeutics·Bette Korber, Will Fischer
Nov 9, 2018·Frontiers in Immunology·Jorge CarrilloJulià Blanco
May 22, 2020·Drugs·Lucia Bailon AlvarezChristian Brander
Jun 30, 2021·Expert Review of Vaccines·Christopher P Karch, Gary R Matyas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.